Trial intelligence / Profile preview

Vitamin D Supplementation in HIV-1 Infected Patients

NCT00306410Phase 2Unknown

Sponsor
Radboud University Medical Center
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing Colecalciferol with Placebo (2 arms). Primary endpoint: Normalization of vitamin D levels at 12 weeks. Status: unknown.

02

Drugs

cholecalciferol
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT00306410.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00306410.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call